Literature DB >> 7962105

Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.

A J Wu1, R H Kurrasch, J Katz, P C Fox, B J Baum, J C Atkinson.   

Abstract

Interferon-gamma (IFN-gamma) is a product of activated T-lymphocytes, and tumor necrosis factor-alpha (TNF-alpha) is a product of both lymphocytes and macrophages. These cell types are often present at sites of tissue damage secondary to chronic infection or autoimmune disease. The purpose of this study was to characterize the effects of TNF-alpha and IFN-gamma on a human submandibular gland epithelial cell line (HSG). IFN-gamma caused a concentration-dependent decrease in HSG cell growth (approximately 70% in 6 days). Conversely, TNF-alpha alone had little effect on the growth of these cells. When these cytokines were added in combination (20 units/ml TNF-alpha and 1,000 units/ml of IFN-gamma), there was a synergistic antiproliferative effect; no apparent cell growth was observed. The cytokine-induced antiproliferative effect was reversible. After the apparent cessation of cell growth for 3-6 days, removal of the cytokines permitted complete growth recovery. Further, cells that recovered and exhibited growth patterns that were similar to control cells remained susceptible to the antiproliferative effects of the cytokines. Flow cytometry revealed that the percentage of cells in G0/G1 with the combination of cytokines was significantly increased by 24 h. The antiproliferative effect of IFN-gamma alone and that of IFN-gamma and TNF-alpha in combination were blocked completely using an antibody to the IFN-gamma receptor. A hypothesized mechanism of tissue damage in autoimmune inflammatory disorders is via up-regulation of cell surface markers such as intercellular adhesion molecule type I (ICAM-1) and histocompatibility antigen HLA-DR which can exacerbate the inflammatory process. Treatment of HSG cells with IFN-gamma, with or without TNF-alpha, resulted in increased levels of ICAM-1 and the acquisition of HLA-DR expression. These aggregate data suggest that IFN-gamma alone can regulate the expression of cell surface markers involved in the inflammatory process as well as cause a potent yet reversible inhibition of HSG cell growth that is modulated by the presence of TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962105     DOI: 10.1002/jcp.1041610205

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Global gene expression profile progression in Gaucher disease mouse models.

Authors:  You-Hai Xu; Li Jia; Brian Quinn; Matthew Zamzow; Keith Stringer; Bruce Aronow; Ying Sun; Wujuan Zhang; Kenneth D R Setchell; Gregory A Grabowski
Journal:  BMC Genomics       Date:  2011-01-11       Impact factor: 3.969

2.  IFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome.

Authors:  Brendan Antiochos; Mariusz Matyszewski; Jungsan Sohn; Livia Casciola-Rosen; Antony Rosen
Journal:  JCI Insight       Date:  2018-09-20

3.  Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.

Authors:  John C Hall; Livia Casciola-Rosen; Alan E Berger; Efstathia K Kapsogeorgou; Chris Cheadle; Athanasios G Tzioufas; Alan N Baer; Antony Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

4.  Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome.

Authors:  R Matsumura; K Umemiya; T Goto; T Nakazawa; M Kagami; H Tomioka; E Tanabe; T Sugiyama; M Sueishi
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

5.  Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function.

Authors:  S M Fish; R Proujansky; W W Reenstra
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

6.  RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.

Authors:  Christopher Chuong; Joseph Katz; Kaleb M Pauley; Marievic Bulosan; Seunghee Cha
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

Review 7.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

8.  Differences of reactivity to interferon gamma in HeLa and CaSki cells: a combined immunocytochemical and flow-cytometric study.

Authors:  G Lizard; M C Chignol; Y Chardonnet; D Schmitt
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.

Authors:  Nienke Roescher; Jelle L Vosters; Hongen Yin; Gabor G Illei; Paul P Tak; John A Chiorini
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

10.  Automated analysis of time-lapse imaging of nuclear translocation by retrospective strategy and its application to STAT1 in HeLa cells.

Authors:  Fujun Han; Peizhou Liang; Feifei Wang; Lingyun Zeng; Biliang Zhang
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.